Rentokil welcomes Nelson Peltz to its board of directors through Trian's appointment.

• Trian partner Brian Baldwin will join the Terminix owner's board next week, as announced by Rentokil Initial on Wednesday.
• Rentokil's accession was announced three months after Trian revealed a $400 million stake in the company and two weeks after the company issued a profit warning.
• Since its acquisition of Terminix in 2021, Rentokil has faced challenges.

The Terminix owner, Rentokil Initial, announced on Wednesday that Brian Baldwin, a partner at Trian, would be joining its board starting next week.

Since 2007, Baldwin has been working at Nelson Peltz's firm and will now join the nominating and compensation committees at Rentokil, where Trian has held a roughly $400 million position since disclosing it three months ago, and the company issued a profit warning two weeks ago.

Since acquiring Terminix for nearly $7 billion in 2022, Rentokil has faced challenges in fully integrating the two businesses. Despite initial optimism from analysts, the company's shares have fallen around 10% year-to-date. However, there was a slight uptick of around 2.7% in Wednesday's trading after the appointment of Baldwin.

Baldwin is a board member of BlackRock, a $335 billion asset management company.

Peltz's Trian has a long history of revitalizing struggling businesses, mainly in the consumer sector. Peltz has served on the boards of , the former company, and . His company recently attempted a proxy fight at Disney, although they were unsuccessful in securing a board seat, they still made approximately $1 billion from the investment.